H. Worth (Fürth, Germany), M. Allen (Staffordshire, United Kingdom)
Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD)
K. S. Srinivasan, A. C. Yeung, C. F. Pantin, M. B. Allen (Stoke-on-Trent, United Kingdom)
|  |
Effect of SGRQ response on health status measured by the SF-6D
J. Brazier, M. D. Spencer, J. Zhu (Sheffield, Greenford, United Kingdom; Collegeville, United States Of America)
| |
Exacerbations during a 6-month trial and health status at end point
J. Brazier, M. D. Spencer, J. Zhu (Sheffield, Greenford, United Kingdom; Collegeville, United States Of America)
| |
Quality review of implementation of a case management model of hospitalized COPD patients
P. Hernandez, C. P. McParland, M. Harris, I. Galloway, R. A. McIvor (Halifax, Canada)
| |
Correlation of exercise testing parameters - six-minutes walking distance, postexercise oxygen saturation and Borg score - with the degree of functional impairment in COPD
D. Gologanu, P. Leru, G. Rusu, C. Tanasescu (Bucharest, Romania)
| |
The health status burden of exacerbation in COPD as measured using the EQ-5D
M. D. Spencer, A. E. Williams (Greenford, Stockley Park, United Kingdom)
| |
Does the chronic respiratory disease questionnaire (CRDQ) relate to hospital admission rates in chronic obstructive pulmonary disease (COPD) patients
K. S. Srinivasan, A. C. Yeung, C. F. Pantin, M. B. Allen (Stoke-on-Trent, United Kingdom)
| |
Health status changes in patients with alpha-1-antitrypsin deficiency
M. Needham, H. M. Wilkins, R. A. Stockley (Birmingham, United Kingdom)
| |
Short-term changes in health status with tiotropium predict long-term changes in health status
S. Spencer, P. W. Jones (London, United Kingdom)
| |
The level of health-related quality of life (HRQL) in patients with moderate to severe COPD and its relationship to symptoms
E. Ståhl, S. A. Jansson, A. C. Jonsson, B. Lundbäck, F. Andersson (Lund, Luleå-Boden, Sweden)
| |
Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler
P. W. Jones, E. Ståhl, K. Svensson (London, United Kingdom; Lund, Sweden)
| |
Is health status a more important determinant of hospital admission rates than lung function in COPD patients
K. S. Srinivasan, A. C. Yeung, C. F. Pantin, M. B. Allen (Stoke-on-Trent, United Kingdom)
| |
The correlation between quality of life, pulmonary functions and anthropometric parameters in COPD patients
S. S Cömert, M. Erk, I. Talasli (Istanbul, Turkey)
| |
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations
J. B. Stroband, T. S. Lapperre, M. S. van Maaren, G. ter Veen, J. Stolk, H. Kerstjens, J. K. Sont, H. A. Thiadens, T. van der Molen, K. F. Rabe, D. S. Postma, P. J. Sterk, the GLUCOLD Study Group (Leiden, The Netherlands)
| |
Analysis of the level of dyspnea and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
O. B. Dimitrijevic, M. D. Filipovic, S. S. Cekic (Nis, Yugoslavia)
| |
Relationship between quality of life and the degree of dyspnea in COPD outpatients
B. S. Gvozdenovic, S. Plavsic, M. Vukovic, S. Milosevic, V. Stanisavljevic (Belgrade, Yugoslavia; Kraljevo, Serbia)
| |
Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations
B. D. Gvozdenovic, B. S. Gvozdenovic (Belgrade, Yugoslavia)
| |
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
J. E. Alonso, A. Sanchez, S. J. Carrizo, J. M. Marin (Zaragoza, Spain)
| |
Analysis of the ability of different health status and dyspnea measures to predict 5-year mortality in COPD
T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, M. Mishima (Kyoto, Kobe, Japan)
| |
Quality of life and health status in COPD
R. M. Wirnsberger, J. De Vries, M. Drent (Hilversum, Tilburg, Maastricht, The Netherlands)
| |